Stay updated on Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Version 35, submitted on 2026-03-16, adds updates to Study Status and Contacts/Locations and updates the record revision to v3.5.0.
    Difference
    0.4%
    Check dated 2026-03-19T04:48:59.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:40:26.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Version 34 updates the record by renaming the study to include Placebo With ADT and adding the Contacts/Locations, Study Design, Study Status, and Study Identification sections. These changes align the study's identification with the protocol and provide essential administrative details for tracking.
    Difference
    0.5%
    Check dated 2026-02-18T16:33:53.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. Removed the government funding lapse notice and operating-status guidance that previously appeared on the page.
    Difference
    0.5%
    Check dated 2026-02-11T11:36:06.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page revision to v3.4.1, with the previous revision v3.4.0 removed.
    Difference
    0.5%
    Check dated 2026-02-04T10:21:47.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page now shows a Show glossary option and a legend for color-coded changes (green for additions, red for deletions). It also introduces the latest revision label (Revision: v3.4.0) and a minor capitalization change in 'No FEAR Act Data'.
    Difference
    0.7%
    Check dated 2026-01-28T06:15:35.000Z thumbnail image

Stay in the know with updates to Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Darolutamide in Hormone Sensitive Prostate Cancer Clinical Trial page.